Biotin supplement for very low birth weight infant
Phase 3
Completed
- Conditions
- very low birth weight infant
- Registration Number
- JPRN-UMIN000025088
- Lead Sponsor
- Ministry of Health, Labour and Welfare
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
congenital malformation syndrome abnormalities of chromosome
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method late onset metabolic acidosis for 3-8 weeks of age
- Secondary Outcome Measures
Name Time Method mortality at discharge neurological morbidity at the age of two years
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie biotin supplementation in very low birth weight infants?
How does biotin supplementation compare to standard-of-care in improving outcomes for VLBW infants?
Are there specific biomarkers that predict response to biotin supplementation in VLBW infants?
What are the potential adverse events associated with biotin supplementation in VLBW infants?
What related compounds or combination therapies are being explored for VLBW infants alongside biotin?